A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy
Conditions: Colorectal Neoplasia Interventions: Drug: Omeprazole; Drug: Aspirin Sponsors: University of Michigan Rogel Cancer Center; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Aspirin | Cancer | Cancer & Oncology | Colorectal Cancer | Omeprazole | Prilosec | Research